| Literature DB >> 27725776 |
Mijeong Park1, Mark J Raftery2, Paul S Thomas1,3, Carolyn L Geczy1, Katherine Bryant1, Nicodemus Tedla1.
Abstract
FcγRI cross-linking on monocytes may trigger clathrin-mediated endocytosis, likely through interaction of multiple intracellular molecules that are controlled by phosphorylation and dephosphorylation events. However, the identity of phospho-proteins and their regulation are unknown. We proposed the leukocyte immunoglobulin-like receptor B4 (LILRB4) that inhibits FcγRI-mediated cytokine production via Tyr dephosphorylation of multiple kinases, may also regulate endocytosis/phagocytosis through similar mechanisms. FcγRI and/or LILRB4 were antibody-ligated on THP-1 cells, lysates immunoprecipitated using anti-pTyr antibody and peptides sequenced by mass spectrometry. Mascot Search identified 25 Tyr phosphorylated peptides with high confidence. Ingenuity Pathway Analysis revealed that the most significantly affected pathways were clathrin-mediated endocytosis and Fc-receptor dependent phagocytosis. Tyr phosphorylation of key candidate proteins in these pathways included common γ-chain of the Fc receptors, Syk, clathrin, E3 ubiquitin protein ligase Cbl, hepatocyte growth factor-regulated tyrosine kinase substrate, tripartite motif-containing 21 and heat shock protein 70. Importantly, co-ligation of LILRB4 with FcγRI caused significant dephosphorylation of these proteins and was associated with suppression of Fc receptor-dependent uptake of antibody-opsonised bacterial particles, indicating that LILRB4. These results suggest that Tyr phosphorylation may be critical in FcγRI-dependent endocytosis/phagocytosis that may be regulated by LILRB4 by triggering dephosphorylation of key signalling proteins.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27725776 PMCID: PMC5057125 DOI: 10.1038/srep35085
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Cross-linking of FcγRI induced Tyr phosphorylation of multiple proteins that were reduced upon co-ligation with LILRB4.
(A) Representative Western blot using anti-pTyr mAb showing marked increases in multiple Tyr phosphorylated proteins in total cell lysate from THP-1 cells ligated with specific mouse anti-FcγRI+IgG1 compared with cells treated with IgG1 alone. Tyr phosphorylated proteins in cells following co-ligation with anti-LILRB4 mAb and anti-FcγRI Ab were markedly reduced and more similar to those in cells treated with anti-LILRB4 mAb alone. The lower panel shows the same membrane stripped and re-probed with anti-β actin Ab confirming comparable protein loading (n = 3 experiments using different batches of THP-1 cells). Migration of the molecular weight markers is shown on the left. (B) Immunoprecipitation using anti-pTyr mAb (4G10) followed by Western blotting with biotinylated anti-pTyr mAb-100 mAb showed multiple strongly phosphorylated proteins in lysates from THP-1 cells cross-linked with specific mouse anti-FcγRI mAb but not control IgG1 (n = 3 separate experiments). (C) Silver staining of SDS-PAGE gels loaded with anti-pTyr mAb-precipitated lysates from FcγRI cross-linked cells indicated enrichment of 8 components that separated at approximately 100, 70, 50, 47, 43, 35, 30 and 14 kDa, compared to precipitates from control IgG1-treated cells. Bands at 53 and 25 kDa that are evident in each sample likely represented the heavy and light chains of antibodies used for immunoprecipitation and were not sequenced (representative of 3 independent experiments using different batches of THP-1 cells). Mascot Search output of peptides sequenced by LC-MS/MS of the 3 experiments combined identified 80 specific hits of 25 Tyr phosphorylated candidate proteins (Mowse score > 50, p 0.05; >3 peptide matches) (see Table 1).
Mascot search results of mass spectrometric peptides sequencing of tyrosine phosphorylated proteins following FcγRI cross linking of THP-1 cells (n = 3).
| 1 | alpha actinin 1, sarcomeric (F-actin cross-linking protein) | 5321 | 249 | 102 |
| alpha actinin 4 | 1927 | 77 | 102 | |
| E3 ubiquitin-protein ligase CBL | 964 | 71 | 99 | |
| hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) | 231 | 17 | 86 | |
| Toll-like receptor 6 | 116 | 12 | 92 | |
| microtuble-associated protein 2 | 123 | 8 | 199 | |
| ALG-2 interacting protein 1 (hp95/ program cell death 6 interacting protein) | 112 | 3 | 96 | |
| phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP1) | 98 | 3 | 133 | |
| 2 | protein Tyr kinase Syk | 951 | 67 | 72 |
| heat shock cognate 71 kDa protein | 831 | 46 | 70 | |
| hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) | 209 | 31 | 86 | |
| actinin, alpha 1 | 654 | 22 | 103 | |
| protein SPY75 (hematopoietic cell-specific Lyn substrate 1) | 289 | 11 | 54 | |
| lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76 kDa) | 287 | 11 | 60 | |
| E3 ubiquitin-protein ligase CBL (proto-oncogene c-CBL, RING finger protein 55) | 146 | 6 | 100 | |
| Fc gamma receptor type I/ Fc fragment of IgG receptor, CD64) | 76 | 4 | 42 | |
| ATP-dependent DNA helicase II, 70 kDa subunit (G22P1) | 64 | 3 | 70 | |
| 3 | elongation factor 1 alpha 1 | 402 | 30 | 50 |
| lymphocyte cytosolic protein 2 (SLP76) | 293 | 27 | 60 | |
| tripartite motif containing 21(TRIM21) | 277 | 21 | 54 | |
| Hematopoietic lineage cell-specific protein | 261 | 13 | 53 | |
| beta-actin | 254 | 10 | 42 | |
| tubulin beta chain | 235 | 10 | 50 | |
| signal transducing adaptor molecule 2B (STAM2) | 232 | 8 | 58 | |
| coronin, actin binding protein, 1C variant | 230 | 7 | 53 | |
| alpha actinin (4) | 227 | 7 | 103 | |
| docking protein 2 | 210 | 6 | 45 | |
| protein Tyr kinase or Syk | 175 | 7 | 72 | |
| ARP3 actin-related protein 3 homolog | 154 | 7 | 47 | |
| signal transducing adaptor molecule 1 (STAM1) | 83 | 4 | 59 | |
| heat shock protein 70 kDa | 93 | 3 | 70 | |
| E3 ubiquitin-protein ligase CBL (Ring finger protein 55) | 97 | 5 | 99 | |
| unnamed human protein (IgG receptor Fc region II precursor) | 78 | 3 | 35 | |
| alpha-tubulin | 74 | 3 | 50 | |
| 4 | ARP3 actin-related protein 3 | 1338 | 61 | 47 |
| mitogen-activated protein kinase 9 | 103 | 4 | 48 | |
| actin non-muscle 6.2 | 504 | 19 | 41 | |
| alpha actinin 4 | 95 | 3 | 102 | |
| actin 7 | 91 | 3 | 37 | |
| docking protein 2 | 79 | 3 | 45 | |
| signal transducing adaptor molecule 2B (STAM2) | 75 | 3 | 58 | |
| 5 | POTE ankyrin domain family member E | 835 | 38 | 35 |
| actin related protein 2/3 complex subunit 1B (p41-ARC) | 577 | 35 | 40 | |
| F-actin capping protein alpha-1 subunit | 480 | 29 | 32 | |
| F-actin capping protein beta subunit (actin filament muscle Z-line) | 208 | 4 | 30 | |
| clathrin light chain (LCB3) | 170 | 8 | 23 | |
| histone cluster1, H1 | 83 | 8 | 23 | |
| capping protein alpha (actin filament muscle Z-line, alpha 2) | 141 | 6 | 33 | |
| actin related protein 2/3 complex subunit 2 | 126 | 5 | 34 | |
| EF-hand domain family, member D2 | 100 | 5 | 27 | |
| protein tyrosine kinase (PTK9 or Twinfilin-1) | 99 | 4 | 40 | |
| protein phosphatase 1 gamma | 97 | 3 | 37 | |
| protein Tyr kinase (Syk) | 80 | 4 | 72 | |
| E3 ubiquitin-protein ligase CBL | 70 | 3 | 100 | |
| 6 | actin related protein 2/3 complex subunit 2 | 515 | 38 | 34 |
| actin related protein 2/3 complex subunit 1B (p41-ARC) | 434 | 17 | 41 | |
| F-actin capping protein beta subunit (actin filament muscle Z-line, beta) | 307 | 15 | 31 | |
| EF-hand domain family, member D2 | 279 | 10 | 27 | |
| linker for activation of T cells family member 2 | 133 | 6 | 31 | |
| F-actin capping protein alpha-1 subunit | 122 | 5 | 33 | |
| high affinity immunoglobulin gamma Fc receptor I | 97 | 5 | 32 | |
| actin related protein 2/3 complex subunit 4 isoform a | 96 | 4 | 20 | |
| Crk-like protein | 58 | 3 | 33 | |
| coatomer subunit epsilon | 56 | 3 | 34 | |
| 7 | spectrin beta chain, non-erythrocyte 4 | 221 | 14 | 28 |
| EF hand domain containing protein D2 | 311 | 17 | 26 | |
| clathrin light chain B | 106 | 13 | 25 | |
| clathrin light chain A | 91 | 8 | 27 | |
| protein tyrosine phosphatase, non-receptor type 18 | 81 | 3 | 50 | |
| 8 | alpha actinin 4 | 2158 | 101 | 102 |
| actinin, alpha 1 | 1607 | 78 | 103 | |
| clathrin heavy chain 1 (or KIAA0034) | 375 | 25 | 191 | |
| E3 ubiquitin-protein ligase CBL | 354 | 13 | 100 | |
| splicing factor proline/glutamine rich | 288 | 16 | 76 | |
| Ubiquitin-40S ribosomal protein s27a | 219 | 17 | 17 | |
| hepatocyte growth factor-regulated tyrosine kinase substrate | 186 | 6 | 62 | |
| high affinity immunoglobulin epsilon receptor subunit gamma | 179 | 5 | 10 | |
| protein Tyr kinase (p72 Syk) | 95 | 4 | 96 | |
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLCG2) | 82 | 3 | 14 |
Figure 2Pathway analysis of Tyr-phosphorylated proteins after FcγRI-cross-linking.
Ingenuity Pathway Analysis of the 80 enriched peptides from the combined 3 experiments showed that clathrin-mediated endocytosis was predicted to be the most enriched signalling pathway (p = 2.19 × 10−13) followed by FcγRI-mediated phagocytosis and integrin signalling (p = 4.11 × 10−13 and p = 1.88 × 10−9) respectively.
Figure 3Co-ligation of LILRB4 with FcγRI suppressed Tyr phosphorylation of multiple proteins involved in clathrin-mediated endocytosis, and of TRIM21.
(A) Representative immunoprecipitation of THP-1 cell lysates using anti-pTyr mAb (4G10) followed by Western blotting using selected antibodies showed abundant Tyr phosphorylation of FcγR s, clatherin, HSP70, Cbl, HGS and TRIM21 in cells co-ligated with anti-FcγRI+IgG1 control mAb validating LC-MS/MS data. Importantly, LILRB4 co-ligation with FcγRI markedly reduced Tyr phosphorylation of all proteins except for HSP70 (n = 3). (B) Summary of densitometry of bands from 3 independent experiments showed significant reduction of FcγRs, clatherin, Cbl, HGS and TRIM21 phosphorylation, but not HSP70, in THP-1 cells co-ligated with anti-FcγRI and anti-LILRB4 mAbs, compared to cells co-ligated with anti-FcγRI and negative control mAb (n = 3, **p < 0.01; ***p < 0.001). (C) Representative Western blotting of total cell lysates showed that co-ligation of FcγRI with LILRB4 did not alter the total amounts of any of the above proteins when compared to co-ligation of FcγRI+IgG1 control, ligation of LILRB4 alone or treatment with IgG1 control alone; the lower panel is the same membrane stripped and re-probed with anti-β actin Ab, confirming comparable protein loading. (D) Summary of densitometry analysis of 3 independent experiments showed no significant differences in total FcγRs, clatherin, HSP70, Cbl, HGS and TRIM21 in THP-1 cells within the 4 different treatment groups (n = 3). Full image of the Western blots is shown in Supplementary Fig. 1. (E) Western blotting of cell lysates from FcγRI cross-linked cells showing increased Tyr-phosphorylated Syk that was markedly reduced upon co-ligation with LILRB4, confirming our earlier finding21 and validating current LC-MS/MS data (Fig. 2) (n = 1).
Figure 4Ligation of LILRB4 significantly suppressed Fc receptor-dependent uptake of antibody-opsonised.
E. coli by differentiated THP-1 cells. (A) Representative dot plot showing uptake of Ab opsonized EGFP-expressing DH5α E-coli particles by 36.7% of PMA-differentiated THP-1 cells (I) that was reduced by 90% when surface FcγRI was blocked by pre-incubating cells with 20 μg/ml anti-FcγRI mAb (II), but not by cells pre-incubated with negative control IgG1 mAb, indicating Fc-receptor dependent endocytosis/phagocytosis (n = 4). Ligation of LILRB4 with mouse anti-LILRB4 mAb followed by goat anti-mouse secondary Ab reduced uptake of Ab opsonized EGFP-expressing DH5α E-coli particles by >50% (III) when compared with non-ligated cells (I). Ligation of control mouse anti-MHC-I mAb (IV) or negative control mouse mAb had little effect on uptake, confirming specific LILRB4-mediated suppression. (B) Summary analysis of 4 independent experiments presenting mean percentages (±SEM) showing that numbers of PMA- differentiated THP-1 cells that took up Ab-opsonized EGFP-expressing DH5α E-coli particles were significantly less if cells were pre-incubated with anti-FcγRI mAb (p = 0.0005), and markedly less following Ab ligation of surface LILRB4 (p = 0.004), but not Ab ligation of MHC-I (p = 0.2).
Figure 5Schematic diagram suggesting possible roles of Tyr phosphorylation of key molecules involved in clathrin-mediated endocytosis of FcγRI and ligands, and their regulation by LILRB4.
Cross-linking of FcγRI by immune-complexes causes Tyr phosphorylation of the ITAMs of its common γ chain and binding of pSyk transduces activating signals. This simultaneously initiates phosphorylation of clatherin that causes lateral diffusion of receptor-ligand complexes to clathrin-coated pits, membrane invagination and generation of clathrin-coated vesicles, and/or initiates phosphorylation of Cbl that may directly ubiquitinate the receptor. Phosphorylated Cbl triggers phosphorylation of HSP70 that facilitates un-coating of the vesicles, a precondition for vesicles to fuse with early endosomes and release ligands. The released receptors are transported to either the late endosome and/or lysosome for proteosomal and/or lysosomal degradation or are recycled to the cell surface. The immune complexes in the endosome are either directly degraded by Cbl, or delivered to the lysosome by phosphorylated HGS-STAM 1/2 complex for final degradation. During transfer, immune complexes that escape the endosome are recognised by phosphorylated TRIM21 for proteasomal degradation. Co-ligation of FcγRI with LILRB4 may recruit phosphatases such as SHP-1 to its ITIMs that subsequently dephosphorylate (deactivate) the key molecules including clathrin (1), FcγRI and Syk (2), Cbl (3), HGS and STAM 1/2 (4) and TRIM21(5). These effects may reduce cellular activation and/or suppress receptor/ligand endocytosis. *New Tyr phosphorylated and dephosphorylated proteins identified in this study.